Neogenomics (NEO) Treasury Shares (2015 - 2026)

Neogenomics (NEO) has 16 years of Treasury Shares data on file, last reported at $3.1 million in Q2 2026.

• Quarterly Treasury Shares changed N/A year-over-year to $3.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.1 million (changed N/A YoY) and the FY2025 annual result came in at $2.8 million, changed N/A from the prior year.
• Treasury Shares was little changed at $25.0 million in Q2 2026.
• In the past five years, Treasury Shares ranged from a high of $3.1 million in Q2 2026 to a low of $838525.0 in Q1 2022.
• A 5-year average of $2.2 million and a median of $2.1 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares jumped 304.82% — and 2023, when it retreated 1.65%.
• Tracing NEO's Treasury Shares over 5 years: stood at $2.0 million in 2022, then decreased by 1.65% to $2.0 million in 2023, then climbed by 12.28% to $2.2 million in 2024, then grew by 28.46% to $2.8 million in 2025, then climbed by 10.44% to $3.1 million in 2026.
• The last three Treasury Shares figures came in at $3.1 million (Q2 2026), $2.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.